John Vega MD
Overview
Dr. Vega is the director of of the heart transplant program at Emory University Hospital and director of cadiothoracic surgery at the Atlanta VA Healthcare System. He implanted Georgia's first dual pump ventricular assist device (VAD) in 1999 to serve as a bridge to heart transplantation, which initiated Emory's ongoing national position at the forefront of the use of mechanical circulatory assist devices. In 2006, he was the first physician in Georgia to implant a VAD as a form of destination therapy for individuals who are ineligible for or are unwilling to undergo a heart transplant, and in 2007 implanted an even smaller VAD for the same purpose.
Dr. Vega has served on the Board of Governors of LifeLink Foundation since 2001. His additional professional memberships have included serving on the Board of Directors of the Organ Procurement and Transplantation Network (OPTN) and United Network for Organ Sharing (UNOS) as the thoracic transplant representative from 2012-2014, chairing the OPTN/UNOS Thoracic Organ Transplantation Committee from 2007-2008, and co-chairing the Thoracic Organ Transplantation Committee of the American Society of Transplant Surgeons from 2008-2011.
In May 2021, Emory University Hospital reached the milestone of 1,000 heart transplants performed, of which Dr. Vega is estimated to have performed nearly half.
Academic Appointment
- Professor of Surgery, Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine
- Attending Physician, Division of Cardiothoracic Surgery, Grady Health System
- Attending Physician, Division of Cardiothoracic Surgery, Wellstar Kennestone Hospital
- Associate Professor, Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine
- Chief, Cardiothoracic Surgery, Veterans Administration Medical Center
- Director, Heart Transplant Program, Emory University Hospital
Education
Degrees
- MD from University of Michigan
- BA from Wake Forest University
Research
Focus
- My research focus is on the surgical treatment of advanced heart failure. This encompasses high-risk coronary bypass,mitral valve repair, heart transplantation,and the use of mechanical circulatory support devices as a bridge to transplant or for Destination Therapy. These treatment options and the underlying disease process offer opportunities for collaboration with basic scientists and participation in clinical trials to advance our understanding of the basic pathophysiology and how these treatment options impact survival and quality of life.
Publications
-
The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device Implantation.
Ann Thorac Surg Volume: 119 Page(s): 907 - 916
04/01/2025 Authors: Pagani FD; Singletary B; Cantor R; Mehaffey JH; Nayak A; Teuteberg J; Shah P; Cowger J; Vega JD; Goldstein D -
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy.
JACC Heart Fail
03/27/2025 Authors: Pagani FD; Netuka I; Jorde UP; Katz JN; Gustafsson F; Connors JM; Uriel N; Soltesz EG; Ivak P; Bansal A -
Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
JACC Heart Fail Volume: 12 Page(s): 1459 - 1469
08/01/2024 Authors: Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko Y-A; Gupta D; Daneshmand M; Vega JD -
The Society of Thoracic Surgeons Intermacs 2023 Annual Report: Focus on Magnetically Levitated Devices.
Ann Thorac Surg Volume: 117 Page(s): 33 - 44
01/01/2024 Authors: Jorde UP; Saeed O; Koehl D; Morris AA; Wood KL; Meyer DM; Cantor R; Jacobs JP; Kirklin JK; Pagani FD -
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
JAMA Volume: 330 Page(s): 2171 - 2181
12/12/2023 Authors: Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J -
Complex repolarization dynamics in ex vivo human ventricles are independent of the restitution properties.
Europace Volume: 25
12/06/2023 Authors: Iravanian S; Uzelac I; Shah AD; Toye MJ; Lloyd MS; Burke MA; Daneshmand MA; Attia TS; Vega JD; El-Chami MF -
Higher-Order Dynamics Beyond Repolarization Alternans in Ex-Vivo Human Ventricles are Independent of the Restitution Properties.
medRxiv
08/21/2023 Authors: Iravanian S; Uzelac I; Shah AD; Toye MJ; Lloyd MS; Burke MA; Daneshmand MA; Attia TS; Vega JD; El-Chami M -
Beyond Alternans: Detection of Higher-Order Periodicity in Ex-Vivo Human Ventricles Before Induction of Ventricular Fibrillation.
bioRxiv
05/02/2023 Authors: Iravanian S; Uzelac I; Shah AD; Toye MJ; Lloyd MS; Burke MA; Daneshmand MA; Attia TS; Vega JD; Merchant FM -
Left Ventricular Assist Devices and Pregnancy: Systematic Review of Existing Literature and Case Report.
Curr Probl Cardiol Volume: 48 Page(s): 101469
02/01/2023 Authors: Yadalam AK; Yoo BW; Horton JP; Krishna I; Vega JD; Bhatt KN; Gupta D; Abdou MH -
Heart transplantation in Val142Ile mutation in the modern era: A single center experience.
Clin Transplant Volume: 36 Page(s): e14780
11/01/2022 Authors: Lyle MA; Brown MT; Morris AA; Gupta D; Vega JD; Cole RT; Bhatt KN